Skip to main content

Table 1 The 2014 therapeutic coverage survey according to the characteristics of participants in each health district

From: Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon

  

Bafia HD

Foumbot-Massangam HD

Yabassi HD

  

n

% (95% CI)

P

n

% (95% CI)

P

n

% (95% CI)

P

Gender

  

0.74

  

0.80

  

0.54

 Female

531

60.6 (47.8–72.1)

 

646

65.6 (55.0–74.9)

 

337

66.0 (56.8–74.2)

 

 Male

496

61.6 (46.9–74.4)

 

594

66.5 (51.4–78.8)

 

305

64.0 (53.2–73.6)

 

Age category (years)

  

< 0.001

  

< 0.001

  

< 0.001

 0–4

82

Non-eligible

 

149

Non-eligible

 

57

Non-eligible

 

 5–9

152

60.5 (44.1–74.7)

 

194

67.6 (51.8–80.2)

 

55

68.9 (57.0–78.7)

 

 10–19

245

66.9 (49.2–80.9)

 

320

75.9 (57.8–87.9)

 

137

75.9 (65.2–84.1)

 

 20–29

160

63.1 (45.8–77.5)

 

193

78.5 (63.5–88.4)

 

123

69.6 (55.5–80.7)

 

 30–39

126

73.8 (58.6–84.8)

 

153

74.3 (58.3–85.7)

 

89

70.6 (58.5–80.4)

 

 40–49

105

77.1 (63.4–86.8)

 

103

87.4 (74.4–94.3)

 

74

74.3 (58.9–85.4)

 

 50–59

71

83.2 (62.8–93.6)

 

76

86.9 (70.7–94.8)

 

56

64.4 (46.8–78.9)

 

 60+

86

78.8 (63.7–88.7)

 

52

80.2 (53.3–93.5)

 

51

79.8 (66.7–88.7)

 

Participants according to the profession of the head of household

0.21

  

0.005

  

0.14

 Civil servant

99

51.1 (35.5–66.5)

 

134

74.3 (61.9–83.7)

 

67

75.4 (56.7–87.8)

 

 Private sector worker

27

72.0 (47.3–88.0)

 

37

93.4 (80.8–98.0)

 

19

84.3 (69.6–95.4)

 

 Farmer

611

65.4 (49.7–78.3)

 

603

63.5 (46.5–77.7)

 

240

59.2 (44.7–72.2)

 

 Trader

72

65.4 (40.8–83.8)

 

136

84.0 (77.3–88.9)

 

30

80.8 (66.9–89.8)

 

 Unskilled worker

52

61.2 (32.4–83.8)

 

106

47.8 (24.3–72.4)

 

89

70.9 (52.9–84.0)

 

 Jobless

163

46.7 (28.2–66.1)

 

219

62.1 (54.0–69.5)

 

190

61.1 (47.4–73.2)

 

Participants according to the educational level of the head of household

0.28

  

0.09

  

0.59

 Never attended school

83

76.6 (49.6–91.6)

 

83

52.8 (26.2–77.9)

 

45

52.7 (21.5–81.9)

 

 Primary school

422

60.4 (43.8–74.9)

 

572

69.0 (54.8–80.4)

 

243

64.1 (51.6–75.0)

 

 Secondary school

469

60.8 (45.1–74.6)

 

540

62.7 (50.0–73.8)

 

299

66.1 (56.5–74.5)

 

 University

51

48.2 (28.7–68.2)

 

45

93.7 (61.0–99.3)

 

52

74.0 (53.5–87.6)

 

History of side effects during past treatments

0.23

  

0.97

  

0.045

 No

935

63.5 (48.8–76.0)

 

1174

67.5 (54.1–78.5)

 

550

65.1 (54.3–74.5)

 

 Yes

59

51.1 (29.7–72.1)

 

32

67.9 (39.8–87.1)

 

72

80.4 (65.6–89.8)

 

Perception of the risk to catch onchocerciasis

0.54

  

0.005

  

0.50

 No

266

66.6 (47.9–81.3)

 

376

81.2 (73.9–86.8)

 

134

61.0 (47.2–73.2)

 

 Yes

757

59.4 (43.0–74.0)

 

859

59.7 (44.0–73.6)

 

508

66.2 (55.5–75.4)

 

Involvement of parents in CDTI

  

0.006

  

< 0.001

  

< 0.001

 High

51

93.0 (75.8–98.3)

 

109

94.4 (86.1–97.9)

 

18

88.6 (69.5–96.4)

 

 Average

91

66.0 (47.8–80.4)

 

193

84.3 (74.7–90.8)

 

79

88.5 (76.2–94.9)

 

 Low

885

58.9 (44.7–71.8)

 

938

59.6 (45.6–72.1)

 

545

61.0 (51.2–69.9)

 

General therapeutic coverage

1027

61.1 (47.7–73.0)

 

1240

66.0 (53.6–76.6)

 

642

65.1 (55.8–73.4)

0.76*

  1. Abbreviations: HD health district, CDTI community-directed treatment with ivermectin; In bold: P-value <5%; *P-value of the comparison between the three HDs